ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biological Hemostatic Material Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-32M13746
Home | Market Reports | Health| Medical Devices & Equipment
Global Biological Hemostatic Material Market Research Report 2023
BUY CHAPTERS

Global Biological Hemostatic Material Market Research Report 2025

Code: QYRE-Auto-32M13746
Report
May 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
BD
Baxter
B. Braun
Cura Medical
Gelita Medical
Curasan
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products

Biological Hemostatic Material Market Size

The global market for Biological Hemostatic Material was valued at US$ 593 million in the year 2024 and is projected to reach a revised size of US$ 887 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Biological Hemostatic Material Market

Biological Hemostatic Material Market

Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biological Hemostatic Material, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Hemostatic Material.
The Biological Hemostatic Material market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Hemostatic Material market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Hemostatic Material manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biological Hemostatic Material Market Report

Report Metric Details
Report Name Biological Hemostatic Material Market
Accounted market size in year US$ 593 million
Forecasted market size in 2031 US$ 887 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Biological Hemostatic Material manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Biological Hemostatic Material in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Biological Hemostatic Material Market growing?

Ans: The Biological Hemostatic Material Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Biological Hemostatic Material Market size in 2031?

Ans: The Biological Hemostatic Material Market size in 2031 will be US$ 887 million.

Who are the main players in the Biological Hemostatic Material Market report?

Ans: The main players in the Biological Hemostatic Material Market are Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences, Zhonghui Shengxi, Beijing Datsing Bio-tech, Guizhou Jin Jiu Biotech, Beijing Taikesiman, Foryou Medical, Saikesaisi Holdings Group, Biotemed, Hangzhou Singclean Medical Products

What are the Application segmentation covered in the Biological Hemostatic Material Market report?

Ans: The Applications covered in the Biological Hemostatic Material Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Biological Hemostatic Material Market report?

Ans: The Types covered in the Biological Hemostatic Material Market report are Collagen, Gelatin, Polysaccharides, Other

Recommended Reports

Hemostatic Agents

Hemostatic Powders & Sponges

Hemostatic Materials & Devices

1 Biological Hemostatic Material Market Overview
1.1 Product Definition
1.2 Biological Hemostatic Material by Type
1.2.1 Global Biological Hemostatic Material Market Value Comparison by Type (2024 VS 2031)
1.2.2 Collagen
1.2.3 Gelatin
1.2.4 Polysaccharides
1.2.5 Other
1.3 Biological Hemostatic Material by Application
1.3.1 Global Biological Hemostatic Material Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Biological Hemostatic Material Market Size Estimates and Forecasts
1.4.1 Global Biological Hemostatic Material Revenue 2020-2031
1.4.2 Global Biological Hemostatic Material Sales 2020-2031
1.4.3 Global Biological Hemostatic Material Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Biological Hemostatic Material Market Competition by Manufacturers
2.1 Global Biological Hemostatic Material Sales Market Share by Manufacturers (2020-2025)
2.2 Global Biological Hemostatic Material Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Biological Hemostatic Material Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Biological Hemostatic Material, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biological Hemostatic Material, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biological Hemostatic Material, Product Type & Application
2.7 Global Key Manufacturers of Biological Hemostatic Material, Date of Enter into This Industry
2.8 Global Biological Hemostatic Material Market Competitive Situation and Trends
2.8.1 Global Biological Hemostatic Material Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Biological Hemostatic Material Players Market Share by Revenue
2.8.3 Global Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biological Hemostatic Material Market Scenario by Region
3.1 Global Biological Hemostatic Material Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Biological Hemostatic Material Sales by Region: 2020-2031
3.2.1 Global Biological Hemostatic Material Sales by Region: 2020-2025
3.2.2 Global Biological Hemostatic Material Sales by Region: 2026-2031
3.3 Global Biological Hemostatic Material Revenue by Region: 2020-2031
3.3.1 Global Biological Hemostatic Material Revenue by Region: 2020-2025
3.3.2 Global Biological Hemostatic Material Revenue by Region: 2026-2031
3.4 North America Biological Hemostatic Material Market Facts & Figures by Country
3.4.1 North America Biological Hemostatic Material Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Biological Hemostatic Material Sales by Country (2020-2031)
3.4.3 North America Biological Hemostatic Material Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biological Hemostatic Material Market Facts & Figures by Country
3.5.1 Europe Biological Hemostatic Material Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Biological Hemostatic Material Sales by Country (2020-2031)
3.5.3 Europe Biological Hemostatic Material Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Hemostatic Material Market Facts & Figures by Region
3.6.1 Asia Pacific Biological Hemostatic Material Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Biological Hemostatic Material Sales by Region (2020-2031)
3.6.3 Asia Pacific Biological Hemostatic Material Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biological Hemostatic Material Market Facts & Figures by Country
3.7.1 Latin America Biological Hemostatic Material Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Biological Hemostatic Material Sales by Country (2020-2031)
3.7.3 Latin America Biological Hemostatic Material Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biological Hemostatic Material Market Facts & Figures by Country
3.8.1 Middle East and Africa Biological Hemostatic Material Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Biological Hemostatic Material Sales by Country (2020-2031)
3.8.3 Middle East and Africa Biological Hemostatic Material Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biological Hemostatic Material Sales by Type (2020-2031)
4.1.1 Global Biological Hemostatic Material Sales by Type (2020-2025)
4.1.2 Global Biological Hemostatic Material Sales by Type (2026-2031)
4.1.3 Global Biological Hemostatic Material Sales Market Share by Type (2020-2031)
4.2 Global Biological Hemostatic Material Revenue by Type (2020-2031)
4.2.1 Global Biological Hemostatic Material Revenue by Type (2020-2025)
4.2.2 Global Biological Hemostatic Material Revenue by Type (2026-2031)
4.2.3 Global Biological Hemostatic Material Revenue Market Share by Type (2020-2031)
4.3 Global Biological Hemostatic Material Price by Type (2020-2031)
5 Segment by Application
5.1 Global Biological Hemostatic Material Sales by Application (2020-2031)
5.1.1 Global Biological Hemostatic Material Sales by Application (2020-2025)
5.1.2 Global Biological Hemostatic Material Sales by Application (2026-2031)
5.1.3 Global Biological Hemostatic Material Sales Market Share by Application (2020-2031)
5.2 Global Biological Hemostatic Material Revenue by Application (2020-2031)
5.2.1 Global Biological Hemostatic Material Revenue by Application (2020-2025)
5.2.2 Global Biological Hemostatic Material Revenue by Application (2026-2031)
5.2.3 Global Biological Hemostatic Material Revenue Market Share by Application (2020-2031)
5.3 Global Biological Hemostatic Material Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Biological Hemostatic Material Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 BD
6.2.1 BD Company Information
6.2.2 BD Description and Business Overview
6.2.3 BD Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BD Biological Hemostatic Material Product Portfolio
6.2.5 BD Recent Developments/Updates
6.3 Baxter
6.3.1 Baxter Company Information
6.3.2 Baxter Description and Business Overview
6.3.3 Baxter Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baxter Biological Hemostatic Material Product Portfolio
6.3.5 Baxter Recent Developments/Updates
6.4 B.Braun
6.4.1 B.Braun Company Information
6.4.2 B.Braun Description and Business Overview
6.4.3 B.Braun Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.4.4 B.Braun Biological Hemostatic Material Product Portfolio
6.4.5 B.Braun Recent Developments/Updates
6.5 Cura Medical
6.5.1 Cura Medical Company Information
6.5.2 Cura Medical Description and Business Overview
6.5.3 Cura Medical Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cura Medical Biological Hemostatic Material Product Portfolio
6.5.5 Cura Medical Recent Developments/Updates
6.6 GELITA MEDICAL
6.6.1 GELITA MEDICAL Company Information
6.6.2 GELITA MEDICAL Description and Business Overview
6.6.3 GELITA MEDICAL Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GELITA MEDICAL Biological Hemostatic Material Product Portfolio
6.6.5 GELITA MEDICAL Recent Developments/Updates
6.7 Curasan AG
6.7.1 Curasan AG Company Information
6.7.2 Curasan AG Description and Business Overview
6.7.3 Curasan AG Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Curasan AG Biological Hemostatic Material Product Portfolio
6.7.5 Curasan AG Recent Developments/Updates
6.8 Meril Life Sciences
6.8.1 Meril Life Sciences Company Information
6.8.2 Meril Life Sciences Description and Business Overview
6.8.3 Meril Life Sciences Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Meril Life Sciences Biological Hemostatic Material Product Portfolio
6.8.5 Meril Life Sciences Recent Developments/Updates
6.9 Zhonghui Shengxi
6.9.1 Zhonghui Shengxi Company Information
6.9.2 Zhonghui Shengxi Description and Business Overview
6.9.3 Zhonghui Shengxi Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zhonghui Shengxi Biological Hemostatic Material Product Portfolio
6.9.5 Zhonghui Shengxi Recent Developments/Updates
6.10 Beijing Datsing Bio-tech
6.10.1 Beijing Datsing Bio-tech Company Information
6.10.2 Beijing Datsing Bio-tech Description and Business Overview
6.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Beijing Datsing Bio-tech Biological Hemostatic Material Product Portfolio
6.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
6.11 Guizhou Jin Jiu Biotech
6.11.1 Guizhou Jin Jiu Biotech Company Information
6.11.2 Guizhou Jin Jiu Biotech Description and Business Overview
6.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product Portfolio
6.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
6.12 Beijing Taikesiman
6.12.1 Beijing Taikesiman Company Information
6.12.2 Beijing Taikesiman Description and Business Overview
6.12.3 Beijing Taikesiman Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Beijing Taikesiman Biological Hemostatic Material Product Portfolio
6.12.5 Beijing Taikesiman Recent Developments/Updates
6.13 Foryou Medical
6.13.1 Foryou Medical Company Information
6.13.2 Foryou Medical Description and Business Overview
6.13.3 Foryou Medical Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Foryou Medical Biological Hemostatic Material Product Portfolio
6.13.5 Foryou Medical Recent Developments/Updates
6.14 Saikesaisi Holdings Group
6.14.1 Saikesaisi Holdings Group Company Information
6.14.2 Saikesaisi Holdings Group Description and Business Overview
6.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Saikesaisi Holdings Group Biological Hemostatic Material Product Portfolio
6.14.5 Saikesaisi Holdings Group Recent Developments/Updates
6.15 Biotemed
6.15.1 Biotemed Company Information
6.15.2 Biotemed Description and Business Overview
6.15.3 Biotemed Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Biotemed Biological Hemostatic Material Product Portfolio
6.15.5 Biotemed Recent Developments/Updates
6.16 Hangzhou Singclean Medical Products
6.16.1 Hangzhou Singclean Medical Products Company Information
6.16.2 Hangzhou Singclean Medical Products Description and Business Overview
6.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Hangzhou Singclean Medical Products Biological Hemostatic Material Product Portfolio
6.16.5 Hangzhou Singclean Medical Products Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Hemostatic Material Industry Chain Analysis
7.2 Biological Hemostatic Material Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Hemostatic Material Production Mode & Process Analysis
7.4 Biological Hemostatic Material Sales and Marketing
7.4.1 Biological Hemostatic Material Sales Channels
7.4.2 Biological Hemostatic Material Distributors
7.5 Biological Hemostatic Material Customer Analysis
8 Biological Hemostatic Material Market Dynamics
8.1 Biological Hemostatic Material Industry Trends
8.2 Biological Hemostatic Material Market Drivers
8.3 Biological Hemostatic Material Market Challenges
8.4 Biological Hemostatic Material Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
BD
Baxter
B. Braun
Cura Medical
Gelita Medical
Curasan
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
List of Tables
 Table 1. Global Biological Hemostatic Material Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Biological Hemostatic Material Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Biological Hemostatic Material Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Biological Hemostatic Material Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Biological Hemostatic Material Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Biological Hemostatic Material Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Biological Hemostatic Material Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Biological Hemostatic Material Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Biological Hemostatic Material, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Biological Hemostatic Material, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Biological Hemostatic Material, Product Type & Application
 Table 12. Global Key Manufacturers of Biological Hemostatic Material, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biological Hemostatic Material by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Hemostatic Material as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biological Hemostatic Material Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Biological Hemostatic Material Sales by Region (2020-2025) & (K Units)
 Table 18. Global Biological Hemostatic Material Sales Market Share by Region (2020-2025)
 Table 19. Global Biological Hemostatic Material Sales by Region (2026-2031) & (K Units)
 Table 20. Global Biological Hemostatic Material Sales Market Share by Region (2026-2031)
 Table 21. Global Biological Hemostatic Material Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Biological Hemostatic Material Revenue Market Share by Region (2020-2025)
 Table 23. Global Biological Hemostatic Material Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Biological Hemostatic Material Revenue Market Share by Region (2026-2031)
 Table 25. North America Biological Hemostatic Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Biological Hemostatic Material Sales by Country (2020-2025) & (K Units)
 Table 27. North America Biological Hemostatic Material Sales by Country (2026-2031) & (K Units)
 Table 28. North America Biological Hemostatic Material Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Biological Hemostatic Material Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Biological Hemostatic Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Biological Hemostatic Material Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Biological Hemostatic Material Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Biological Hemostatic Material Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Biological Hemostatic Material Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Biological Hemostatic Material Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Biological Hemostatic Material Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Biological Hemostatic Material Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Biological Hemostatic Material Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Biological Hemostatic Material Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Biological Hemostatic Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Biological Hemostatic Material Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Biological Hemostatic Material Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Biological Hemostatic Material Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Biological Hemostatic Material Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Biological Hemostatic Material Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Biological Hemostatic Material Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Biological Hemostatic Material Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Biological Hemostatic Material Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Biological Hemostatic Material Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Biological Hemostatic Material Sales (K Units) by Type (2020-2025)
 Table 51. Global Biological Hemostatic Material Sales (K Units) by Type (2026-2031)
 Table 52. Global Biological Hemostatic Material Sales Market Share by Type (2020-2025)
 Table 53. Global Biological Hemostatic Material Sales Market Share by Type (2026-2031)
 Table 54. Global Biological Hemostatic Material Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Biological Hemostatic Material Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Biological Hemostatic Material Revenue Market Share by Type (2020-2025)
 Table 57. Global Biological Hemostatic Material Revenue Market Share by Type (2026-2031)
 Table 58. Global Biological Hemostatic Material Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Biological Hemostatic Material Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Biological Hemostatic Material Sales (K Units) by Application (2020-2025)
 Table 61. Global Biological Hemostatic Material Sales (K Units) by Application (2026-2031)
 Table 62. Global Biological Hemostatic Material Sales Market Share by Application (2020-2025)
 Table 63. Global Biological Hemostatic Material Sales Market Share by Application (2026-2031)
 Table 64. Global Biological Hemostatic Material Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Biological Hemostatic Material Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Biological Hemostatic Material Revenue Market Share by Application (2020-2025)
 Table 67. Global Biological Hemostatic Material Revenue Market Share by Application (2026-2031)
 Table 68. Global Biological Hemostatic Material Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Biological Hemostatic Material Price (US$/Unit) by Application (2026-2031)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Johnson & Johnson Biological Hemostatic Material Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. BD Company Information
 Table 76. BD Description and Business Overview
 Table 77. BD Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BD Biological Hemostatic Material Product
 Table 79. BD Recent Developments/Updates
 Table 80. Baxter Company Information
 Table 81. Baxter Description and Business Overview
 Table 82. Baxter Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Baxter Biological Hemostatic Material Product
 Table 84. Baxter Recent Developments/Updates
 Table 85. B.Braun Company Information
 Table 86. B.Braun Description and Business Overview
 Table 87. B.Braun Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. B.Braun Biological Hemostatic Material Product
 Table 89. B.Braun Recent Developments/Updates
 Table 90. Cura Medical Company Information
 Table 91. Cura Medical Description and Business Overview
 Table 92. Cura Medical Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cura Medical Biological Hemostatic Material Product
 Table 94. Cura Medical Recent Developments/Updates
 Table 95. GELITA MEDICAL Company Information
 Table 96. GELITA MEDICAL Description and Business Overview
 Table 97. GELITA MEDICAL Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GELITA MEDICAL Biological Hemostatic Material Product
 Table 99. GELITA MEDICAL Recent Developments/Updates
 Table 100. Curasan AG Company Information
 Table 101. Curasan AG Description and Business Overview
 Table 102. Curasan AG Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Curasan AG Biological Hemostatic Material Product
 Table 104. Curasan AG Recent Developments/Updates
 Table 105. Meril Life Sciences Company Information
 Table 106. Meril Life Sciences Description and Business Overview
 Table 107. Meril Life Sciences Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Meril Life Sciences Biological Hemostatic Material Product
 Table 109. Meril Life Sciences Recent Developments/Updates
 Table 110. Zhonghui Shengxi Company Information
 Table 111. Zhonghui Shengxi Description and Business Overview
 Table 112. Zhonghui Shengxi Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Zhonghui Shengxi Biological Hemostatic Material Product
 Table 114. Zhonghui Shengxi Recent Developments/Updates
 Table 115. Beijing Datsing Bio-tech Company Information
 Table 116. Beijing Datsing Bio-tech Description and Business Overview
 Table 117. Beijing Datsing Bio-tech Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Beijing Datsing Bio-tech Biological Hemostatic Material Product
 Table 119. Beijing Datsing Bio-tech Recent Developments/Updates
 Table 120. Guizhou Jin Jiu Biotech Company Information
 Table 121. Guizhou Jin Jiu Biotech Description and Business Overview
 Table 122. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product
 Table 124. Guizhou Jin Jiu Biotech Recent Developments/Updates
 Table 125. Beijing Taikesiman Company Information
 Table 126. Beijing Taikesiman Description and Business Overview
 Table 127. Beijing Taikesiman Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Beijing Taikesiman Biological Hemostatic Material Product
 Table 129. Beijing Taikesiman Recent Developments/Updates
 Table 130. Foryou Medical Company Information
 Table 131. Foryou Medical Description and Business Overview
 Table 132. Foryou Medical Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Foryou Medical Biological Hemostatic Material Product
 Table 134. Foryou Medical Recent Developments/Updates
 Table 135. Saikesaisi Holdings Group Company Information
 Table 136. Saikesaisi Holdings Group Description and Business Overview
 Table 137. Saikesaisi Holdings Group Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Saikesaisi Holdings Group Biological Hemostatic Material Product
 Table 139. Saikesaisi Holdings Group Recent Developments/Updates
 Table 140. Biotemed Company Information
 Table 141. Biotemed Description and Business Overview
 Table 142. Biotemed Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Biotemed Biological Hemostatic Material Product
 Table 144. Biotemed Recent Developments/Updates
 Table 145. Hangzhou Singclean Medical Products Company Information
 Table 146. Hangzhou Singclean Medical Products Description and Business Overview
 Table 147. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Hangzhou Singclean Medical Products Biological Hemostatic Material Product
 Table 149. Hangzhou Singclean Medical Products Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Biological Hemostatic Material Distributors List
 Table 153. Biological Hemostatic Material Customers List
 Table 154. Biological Hemostatic Material Market Trends
 Table 155. Biological Hemostatic Material Market Drivers
 Table 156. Biological Hemostatic Material Market Challenges
 Table 157. Biological Hemostatic Material Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biological Hemostatic Material
 Figure 2. Global Biological Hemostatic Material Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biological Hemostatic Material Market Share by Type: 2024 & 2031
 Figure 4. Collagen Product Picture
 Figure 5. Gelatin Product Picture
 Figure 6. Polysaccharides Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Biological Hemostatic Material Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Biological Hemostatic Material Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Other
 Figure 13. Global Biological Hemostatic Material Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Biological Hemostatic Material Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Biological Hemostatic Material Sales (2020-2031) & (K Units)
 Figure 16. Global Biological Hemostatic Material Average Price (US$/Unit) & (2020-2031)
 Figure 17. Biological Hemostatic Material Report Years Considered
 Figure 18. Biological Hemostatic Material Sales Share by Manufacturers in 2024
 Figure 19. Global Biological Hemostatic Material Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Biological Hemostatic Material Players: Market Share by Revenue in Biological Hemostatic Material in 2024
 Figure 21. Biological Hemostatic Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Biological Hemostatic Material Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Biological Hemostatic Material Sales Market Share by Country (2020-2031)
 Figure 24. North America Biological Hemostatic Material Revenue Market Share by Country (2020-2031)
 Figure 25. United States Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Biological Hemostatic Material Sales Market Share by Country (2020-2031)
 Figure 28. Europe Biological Hemostatic Material Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Biological Hemostatic Material Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Biological Hemostatic Material Revenue Market Share by Region (2020-2031)
 Figure 36. China Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Biological Hemostatic Material Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Biological Hemostatic Material Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Biological Hemostatic Material Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Biological Hemostatic Material Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Biological Hemostatic Material Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Biological Hemostatic Material by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Biological Hemostatic Material by Type (2020-2031)
 Figure 55. Global Biological Hemostatic Material Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Biological Hemostatic Material by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Biological Hemostatic Material by Application (2020-2031)
 Figure 58. Global Biological Hemostatic Material Price (US$/Unit) by Application (2020-2031)
 Figure 59. Biological Hemostatic Material Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Active Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medical Hemostatic Agents Market
Hemostatic and Tissue Sealing Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Materials in Wound Care Market Research Report 2024
Global Absorbable Hemostatic Agents Market Research Report 2024
Global Medical Topical Hemostatic Agent Market Research Report 2025
Biodegradable Hemostatic Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tissue Sealing Agents and Hemostasis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostasis and Tissue Sealing Agents Market Insights Forecast to 2030
Clinical Hemostatic Material Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hemostat Powder and Tissue Sealing Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fibrin Glue Hemostat Market Research Report 2024
Global Synthetic Hemostatic Products Market Research Report 2024
Global Hemostatic Sealants Market Research Report 2025
Hemostat Powder and Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Surgical Hemostatic Material Market Research Report 2025
Surgical Hemostatic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clinical Absorbable Hemostat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hemostatic Agents and Tissue Sealants Market Research Report 2025
Global Hemostatic Powders and Hemostatic Agents Market Research Report 2025

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions